|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01801 INNOVENT BIO
Nominal 
51.000 +1.050 (+2.102%) Non-current Assets
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Investment Properties | 0 | -- | 0 | 0 | 0 | 0 |
| Property, plant, equip. & others | 5,279,611 | 23.075% | 4,289,734 | 3,411,496 | 2,692,986 | 1,584,079 |
| Land & other Lease Assets | 367,631 | 0.268% | 366,650 | 414,650 | 396,862 | 327,124 |
| Intangible Assets | 1,282,603 | 0.971% | 1,270,267 | 1,198,163 | 772,194 | 32,625 |
| Interests in Asso. & JCEs | 858,991 | -- | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 3,540,929 | 178.217% | 1,272,724 | 1,057,828 | 830,822 | 424,487 |
| 11,329,765 | 57.372% | 7,199,375 | 6,082,137 | 4,692,864 | 2,368,315 | |
Current Assets
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Inventories | 822,167 | -15.073% | 968,088 | 1,428,882 | 1,347,240 | 705,658 | |
| Trade Receivables | 1,184,407 | 17.747% | 1,005,891 | 575,269 | 968,405 | 475,378 | |
| Cash & Bank Balances | 7,508,185 | -25.307% | 10,052,095 | 9,162,823 | 8,377,095 | 7,763,833 | |
| Other Current Assets | 758,078 | -45.925% | 1,401,911 | 339,734 | 858,109 | 521,812 | |
| Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | |
| 10,272,837 | -23.497% | 13,427,985 | 11,506,708 | 11,550,849 | 9,466,681 | ||
Current Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |||
| Trade Payables | 357,677 | -3.992% | 372,549 | 325,622 | 195,050 | 120,620 | ||
| S-T Debt & Leases | 413,929 | -66.081% | 1,220,330 | 914,392 | 387,273 | 271,157 | ||
| Other Current Liabilities | 3,597,263 | 24.734% | 2,883,937 | 2,259,184 | 2,467,724 | 1,094,074 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | ||
| 4,368,869 | -2.411% | 4,476,816 | 3,499,198 | 3,050,047 | 1,485,851 | |||
| Net Current Assets | 5,903,968 | -34.042% | 8,951,169 | 8,007,510 | 8,500,802 | 7,980,830 | ||
| Total Assets Less Current Liabilities | 17,233,733 | 6.707% | 16,150,544 | 14,089,647 | 13,193,666 | 10,349,145 | ||
Non-current Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||||
| L-T Debt & Leases | 2,417,114 | 0.705% | 2,400,199 | 2,314,116 | 2,109,653 | 935,411 | |||
| Other Non-current Liabilities | 1,698,890 | 38.939% | 1,222,764 | 1,045,582 | 753,616 | 633,964 | |||
| 4,116,004 | 13.609% | 3,622,963 | 3,359,698 | 2,863,269 | 1,569,375 | ||||
Capital and Reserves
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |||||
| Share Capital | 113 | 0.893% | 112 | 105 | 101 | 97 | ||||
| Reserves | 13,117,616 | 4.711% | 12,527,469 | 10,729,844 | 10,330,296 | 8,779,673 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Shareholders' Funds | 13,117,729 | 4.711% | 12,527,581 | 10,729,949 | 10,330,397 | 8,779,770 | ||||
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| 13,117,729 | 4.711% | 12,527,581 | 10,729,949 | 10,330,397 | 8,779,770 | |||||
Commitments and Contingent Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Commitments | -- | -- | 1,157,104 | 1,464,249 | 1,647,517 | 731,142 |
| Contingent Liabilities | -- | -- | 0 | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 16/05/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -94,631 |
| %Change | -90.794% |
| EPS / (LPS) | RMB -0.060 |
| NBV Per Share (¥) | RMB 8.008 |